SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-21-049123
Filing Date
2021-08-02
Accepted
2021-08-02 19:27:35
Documents
1
Period of Report
2021-07-29

Document Format Files

Seq Description Document Type Size
1 FORM 3/A SUBMISSION doc3a.html 3/A  
1 FORM 3/A SUBMISSION doc3a.xml 3/A 5933
  Complete submission text file 0001209191-21-049123.txt   7303
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Issuer) CIK: 0001856725 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RANI THERAPEUTICS HOLDINGS, INC. 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address
Imran Talat (Reporting) CIK: 0001869579 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-40672 | Film No.: 211137386